Last reviewed · How we verify
beta Thalassemia
Approved treatments
- Reblozyl · EuroBloodNet Association
- Exjade · DisperSol Technologies, LLC
- REBLOZYL · CELGENE CORP
- Reblozyl · Celgene Corp
Reblozyl works by binding to growth/differentiation factor 11, promoting the maturation of red blood cells. - Exjade · Novartis
Exjade works by binding to iron in the body and removing it through the urine. - Ferriprox · Chiesi
Ferriprox works by binding to iron in the body and removing it, thereby reducing iron overload.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- beta Thalassemia patent landscape — cliff calendar, originator estates, attackable patents
- beta Thalassemia treatment landscape brief
- beta Thalassemia treatment updates RSS
Frequently asked questions about beta Thalassemia
What drugs treat beta Thalassemia?
Tracked treatments include Reblozyl, Exjade, REBLOZYL, Ferriprox.
What is the treatment for beta Thalassemia?
Standard treatment for beta Thalassemia includes Reblozyl, Exjade, REBLOZYL, Ferriprox. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: beta Thalassemia patent cliff · beta Thalassemia CI report
- Treatment: Reblozyl · EuroBloodNet Association
- Treatment: Exjade · DisperSol Technologies, LLC
- Treatment: REBLOZYL · CELGENE CORP
- Treatment: Reblozyl · Celgene Corp
- Treatment: Exjade · Novartis
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing